This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Cost-Utility of Interferon Beta-1b in the Treatment of Patientswith a Clinically Isolated Syndrome Suggestive of Multiple Sclerosis

Caloyeras, Wang, Bauer, Lee, Lanius, Gondek
Abt Bio-Pharma Solutions, Inc., Lexington, Massachusetts, USA


June 1, 2008
Focus Areas